Michael Christman, PhD, is the president and CEO of the Coriell Institute, as well as the Principal Investigator of the CPMC research study. Under Mike's leadership, Coriell has established a state-of-the-art Genotyping and Microarray Center and formed partnerships with several hospitals to enroll volunteer study participants into the CPMC research study.

Mark Bellafante
Mark Bellafante is the director of information technology at Coriell. He oversees all software development at the Institute. Mark also manages the daily IT activities that support the CPMC research study by working closely with the project scientists and IT application developers. 

Dorit Berlin, PhD
Dorit Berlin, PhD, is a senior research scientist at Coriell. In addition to assisting with the creation of gene-drug pair analyses and reports for CPMC study participants, Dorit also helps to develop educational materials and resources. 

Norman Gerry, PhD, is the director of Coriell's Genotyping and Microarray Center. Norman has been involved in microarray analyses and DNA testing for several years and has successfully processed thousands of microarrays. He and his team are responsible for performing the genetic testing for all CPMC study participants.

Neda Gharani, PhD, a research analyst for the CPMC study, is responsible for searching worldwide scientific literature and reviewing association studies to identify variants for submission to the Informed Cohort Oversight Board. Neda is also developing a protocol for assessing and reporting personalized disease risk based on personal genetic, demographic, and behavioral risk factors.

Erynn Gordon, MS, CGC, is the study's director of genetic counseling. Erynn develops educational materials for study participants and health professionals and is available to provide free genetic counseling to study participants and their physicians by phone, email and/or in person.

Joseph Jarvis, PhD
Joseph Jarvis, PhD, is a senior research scientist for the CPMC study. He is involved in the statistical and bioinformatics analyses that support submissions to the Informed Cohort Oversight Board, as well as the development of the risk reporting algorithms used to deliver personalized results to participants. 

Courtney Kronenthal, PhD, director of communications and development at Coriell, is responsible for community and media outreach and fundraising efforts surrounding the institute and its research programs, including the CPMC research study. Courtney hosts informed consent sessions for individuals interested in enrolling in the CPMC, and together with her team, engage study participants to keep them informed about the study.

Tara Schmidlen, MS, CGC
Tara Schmidlen, MS, CGC, is a genetic counselor for the CPMC. In this role, Tara develops educational materials for study participants and health professionals and is available to provide free genetic counseling to study participants and their physicians by phone, email and/or in person.